Medicine & Life Sciences
Cost-Benefit Analysis
100%
Systematic Reviews
97%
Human Influenza
60%
Economic Models
46%
Vaccination
46%
Azathioprine
36%
Kidney Transplantation
31%
Psychotic Disorders
30%
Neuroimaging
30%
Child
28%
Health Personnel
28%
Immunosuppressive Agents
27%
Mycophenolic Acid
26%
Tacrolimus
24%
Cyclosporine
23%
Delivery of Health Care
20%
Mortality
17%
Internet
15%
Basiliximab
15%
Steroids
15%
Epidemics
14%
Biopsy
13%
Sirolimus
13%
Transplants
12%
Databases
11%
Pediatrics
11%
Tomography
11%
Randomized Controlled Trials
11%
Graft Rejection
11%
Magnetic Resonance Imaging
10%
Costs and Cost Analysis
10%
Daclizumab
7%
Meta-Analysis
5%
Therapeutics
5%
Hyperlipidemias
5%
Social Sciences
contagious disease
64%
vaccination
64%
economic model
38%
psychosis
38%
evaluation
37%
costs
37%
economics
35%
mortality
31%
evidence
30%
Healthcare
25%
worker
20%
community research
19%
resources
14%
cause
13%
electronics
13%
inclusion
11%
life years
11%
Internet
10%
Group
6%
scenario
6%
withdrawal
5%
Agriculture & Biology
systematic review
86%
influenza
77%
economic evaluation
62%
vaccination
52%
health care workers
41%
health services
34%
economic valuation
17%
electronics
15%
experimental design
13%
at-risk population
9%
cost effectiveness
8%
adverse effects
6%
uptake mechanisms
5%